Pharmacy Practice
Affordable Medicines
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
NEUROLOGY
March 17, 2023
Current Monoclonal Antibody Options for Multiple Sclerosis
Disease-modifying therapies, including monoclonal antibodies, are the standard of care for multiple sclerosis because these agents slow disease progression while reducing relapse frequency and severity.
March 17, 2023
Pain-Management Approaches for Peripheral Neuropathy
February 17, 2023
Stroke Rates and Hospitalizations
January 26, 2023
Assisted Reproduction Technology and Risk of Developing MS
January 26, 2023
Study Reveals Gender Differences in Cluster Headaches
January 19, 2023
Lamotrigine 1 mg/mL Compounded Oral Suspension, USP
January 19, 2023
Community Pharmacists’ Role in the Treatment of Epilepsy
January 19, 2023
Risks and Considerations for Epilepsy
January 19, 2023
Managing Glaucoma
January 19, 2023
Severe Drug-Induced Neurologic Disorders
January 19, 2023
Carpal Tunnel Syndrome
January 19, 2023
Neurologic Lyme Disease and the Role of the Pharmacist
January 19, 2023
Diagnosing and Managing Neuromyelitis Optica
Load More
X
March 2023
In This Issue
Digital Magazine
Archives
Subscription
Related CE
$6.97 Per CE Exam or $59 for 12 Lessons
Aducanumab for the Treatment of Alzheimer’s Disease
The Pharmacologic Management of Migraine
×
Full Image